Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Obesity is a condition characterized by excessive accumulation and storage of adipose tissue. Obesity is most commonly quantified by body mass index (BMI), the ratio of a person's weight (in kilograms) to the square of their height (in meters). The Centers for Disease Control and Prevention and the World Health Organization provide definitions of obesity ( Table 29.1 ). , Measuring the degree of obesity is of clinical relevance, because with increasing severity, there are adverse metabolic, biomechanical, and psychosocial health consequences. Although BMI is a simple and reproducible measure of obesity and its related metabolic risk, it does not account for sex- or ethnic-related differences, muscle mass, adipose tissue distribution, or frame size. Additional methods to quantitatively assess obesity include abdominal circumference, body fat percentage, and waist-to-hip ratio.
BMI | |
---|---|
Preferred BMI | 18.5–24.9 kg/m² |
Overweight | 25.0–29.9 kg/m² |
Class I obesity | 30.0–34.9 kg/m² |
Class II obesity | 35.0–39.9 kg/m² |
Class III obesity | ≥40.0 kg/m² |
Obesity is a complex disease with its morbidity affecting every organ system in the body ( Table 29.2 ). Associated conditions that are most likely to impact anesthesia care include pulmonary (obstructive sleep apnea, obesity hypoventilation syndrome, restrictive pulmonary physiology with impaired ventilation-perfusion matching, and reduced functional residual capacity with related rapid desaturation during apnea); cardiovascular (hypertension with related structural heart disease, pulmonary hypertension with cor pulmonale); and endocrine (insulin resistance and diabetes mellitus) disorders.
Organ System | Associated Conditions |
---|---|
Central nervous system | Cognitive decline, dementia Depression |
Respiratory system | Obstructive sleep apnea Obesity hypoventilation syndrome Restrictive lung disease |
Cardiovascular system | Arrhythmias Systemic hypertension Coronary arterial disease Congestive heart failure Pulmonary hypertension Cor pulmonale Cerebrovascular disease Peripheral vascular disease Venous thromboembolism Hypercholesterolemia Hypertriglyceridemia Sudden cardiac death |
Endocrine system | Metabolic syndrome Diabetes mellitus Cushing syndrome Hypothyroidism Infertility |
Gastrointestinal system | Hiatal hernia Gastroesophageal reflux disease Nonalcoholic steatohepatitis Fatty infiltration of the liver Cholelithiasis |
Musculoskeletal system | Degenerative joint disease Osteoarthritis Joint pain Inguinal hernia |
Malignancy | Breast Gastric Pancreatic Liver, gallbladder Kidney Prostate Cervical, uterine, endometrial Colorectal |
Other | Kidney failure Hypercoagulable syndromes Shorter life expectancy |
Obesity is independently associated with various adverse outcomes in the perioperative setting, including greater hospital length of stay, greater estimated blood loss, longer operative times, increased surgical site infections, increased risk of renal failure, and prolonged assisted ventilation. As a BMI calculation alone may not accurately predict metabolic health and comorbid conditions because of its previously mentioned limitations, a complete systems-based assessment is essential for determining a patient's perioperative risk (also see Chapter 13 ).
The combination of the metabolic risk factors associated with obesity is called metabolic syndrome . Metabolic syndrome is an important risk factor for the subsequent development of type 2 diabetes mellitus (T2DM) and/or cardiovascular disease, and its diagnosis is associated with a higher risk of morbidity after surgery. There are six components to metabolic syndrome: abdominal obesity, atherogenic dyslipidemia, hypertension, insulin resistance, proinflammatory state, and prothrombotic state. Because the metabolic traits cooccur, a diagnosis of metabolic syndrome can be made in the presence of just three of the following five criteria: abdominal obesity, increased serum triglycerides, decreased high-density lipoproteins, hypertension, and increased fasting blood glucose levels.
The development and maintenance of obesity are multifactorial and involve genetic, neuroendocrine, environmental, and psychosocial factors. The major therapeutic goals in these patients are to focus on weight reduction and increased physical activity and to pharmacologically treat the previously mentioned metabolic disturbances if they persist despite lifestyle modification.
Changes in anatomy and physiology related to obesity affect anesthetic planning and management. Preoperative assessment should focus on determining the presence and status of comorbid conditions. This assessment will allow for measures to be taken to minimize the risk of perioperative complications, including determining if certain additional testing is required, if the patient is scheduled at an appropriate surgical venue, and if adequate postoperative resources are available if needed.
Standard preoperative fasting guidelines should be observed and the decision to use aspiration prophylaxis made on an individual basis for those patients who are high risk or symptomatic. Careful consideration should be made regarding the use of sedative premedication to achieve anxiolysis, as patients with obesity may be more sensitive to the respiratory depressant effects. If used, these should be given in incremental doses and carefully titrated to effect.
Depending on the habitus of the patient, several logistical challenges may be encountered related to monitoring, procedures, and positioning. The amount and distribution of subcutaneous fat in the extremities may make obtaining peripheral intravenous access difficult and necessitate central venous access depending on the procedure. Similarly, the increased width or conical shape of the upper arms may make the use of a noninvasive blood pressure cuff inaccurate or unreliable and necessitate alternative cuff location (forearm or lower leg) or invasive arterial line access for blood pressure monitoring. As operative room tables are often narrow, positioning may be a challenge (also see Chapter 19 ). Additional reinforcement or pressure point padding may be required to ensure adequate security and support, especially in the event that extreme angles of tilt are required for the procedure.
Before induction of anesthesia, an airway assessment should be made to determine risk factors for difficult mask ventilation or laryngeal intubation (also see Chapter 16 ). Securing an airway in patients with obesity may be challenging because of the redundancy of oropharyngeal tissue, increased neck circumference, reduced mobility of the cervical spine, or increased anterior-posterior chest dimension. Induction of anesthesia may also be complicated by rapid desaturation with apnea. A rapid decrease in blood oxygen saturation is multifactorial with causes including increased metabolic requirements (increased oxygen consumption and carbon dioxide production) and reduced functional residual capacity. , Ensuring adequate preoxygenation or providing apneic oxygenation allows for increased time to desaturation. Optimizing positioning by placing the patient in reverse Trendelenburg (back up or ramped position) will increase functional residual capacity by reducing atelectasis in dependent areas of the lung, improve ventilation-perfusion matching, and caudally displace chest tissue to allow for easier mask ventilation and view on laryngoscopy.
No anesthetic type has proven superior in patients with obesity. However, in patients with elevated risk for respiratory or airway-related problems regional anesthesia should be considered if feasible. When general anesthesia is used, ventilatory management may be challenging and require additional pressure support or positive end-expiratory pressure to ensure adequate ventilation and avoid alveolar collapse. Choice of medications depends on patient-specific factors and comorbidities with consideration of altered drug metabolism and elimination with increased adipose tissue. As mentioned previously, anesthetic medications should be administered in incremental doses and titrated to effect to avoid oversedation or hypoventilation on emergence or postextubation. Ensuring adequate extubation criteria is important, as sedation or interim airway swelling and edema from the surgery or positioning may further complicate an already challenging intubation. As patients with obesity are at increased risk for postoperative pulmonary complications, including hypoxemia or hypercarbia from atelectasis, hypoventilation, or airway obstruction, additional noninvasive ventilatory support in the recovery room may be required to ensure adequate ventilation and gas exchange.
Adult bariatric surgery is a therapeutic option in patients with severe obesity who have failed conservative treatments, such as lifestyle modifications and medical management. Bariatric surgery results in significant sustained weight loss and a reduction in obesity-related comorbidities and cardiovascular events. The strategic approaches for surgically assisted weight loss fall into three categories: gastric restriction, intestinal malabsorption, or a combination of both.
Malabsorptive procedures include jejunoileal bypass or biliopancreatic diversion. These operations have the advantage of promoting significant weight loss by extensively bypassing the small intestine. Although these were the most commonly performed approaches when bariatric surgery was first created, they are now infrequently performed because of their related nutritional and metabolic complications.
Restrictive procedures include gastric banding and sleeve gastrectomy. By creating a small gastric pouch and outlet, these procedures promote weight loss through several mechanisms, including appetite suppression and early satiety, reduced secretion of gastric hormones (i.e., ghrelin), and possibly vagal nerve compression. Whereas sleeve gastrectomies involve resection of the greater curvature of the stomach, banding procedures use adjustable or fixed bands to wrap the top portion of the stomach to the desired size. Gastric banding has fewer complications and lower morbidity and mortality, as it requires no cutting into gastrointestinal structures. Restrictive-based procedures take a longer time to achieve weight loss. However, the normal absorptive physiology of the small intestine is left intact, and nutritional deficiencies rarely occur.
The most common combined bariatric procedure is the Roux-en-Y gastric bypass. This procedure involves creating a small gastric pouch, which is then connected to the jejunum. It is the most complex of the approaches and requires the longest operative time and hospital length of stay. Because of its combined gastric restriction and malabsorption approaches, it promotes the greatest weight loss and improvement in obesity-related comorbidities; however, these patients require lifelong nutritional surveillance and supplementation. As such, it is often reserved for patients with clinically severe obesity.
Bariatric surgeries are often performed laparoscopically because of the benefits of decreased pain, decreased complication rates, shorter recovery times, and outcome efficacy comparable to that of their open counterparts. In addition to the weight loss and high-resolution rate of comorbid conditions such as hypertension and diabetes, patients report improvement in their quality of life. Overall, perioperative mortality from bariatric surgeries ranges from 0.1% to 2.0%, with gastric banding having the lowest mortality and Roux-en-Y gastric bypass having the highest. Risk factors for mortality include male sex, older age, BMI ≥50.0 kg/m², diabetes mellitus, obstructive sleep apnea, and performance at a low-volume bariatric surgical center.
Malnourishment is an imbalance between energy expenditure and energy intake. This term may refer to excessive intake, such as occurs in individuals with obesity, or deficient intake, such as occurs in individuals with undernutrition. For the purpose of this section, malnutrition will be used synonymously with undernutrition. In undernutrition, the supply of nutrients and energy to the body does not meet the demand necessary for cellular growth, maintenance, and function. Undernutrition can be divided into four subforms: wasting (low weight for height), shunting (low height for age), underweight (low weight for age), and micronutrient deficient. Malnourishment may occur as a result of a variety of pathologic and environmental causes and presents in a variety of forms. To account for this variation, the Global Leadership Initiative on Malnutrition developed a consensus on the diagnostic criteria for malnutrition that requires the combination of at least one phenotype and one etiologic criteria: nonvolitional weight loss, low BMI, or reduced muscle mass (phenotype criteria) or reduced food intake or absorption, or underlying inflammation resulting from acute disease/injury or chronic disease (etiologic criteria). 15
Malnutrition is a complex metabolic disorder, involving inflammatory and neurohumoral mediators, which, when severe, affect every organ system in the body ( Table 29.3 ).
Organ System | Features |
---|---|
Central nervous system | Psychological disturbance, depression Depressed cognitive function Fatigue and generalized weakness |
Cardiovascular system | Reduction in cardiac output Increased vagal tone Conduction abnormalities, arrhythmias Peripheral vasoconstriction |
Respiratory system | Reduced respiratory muscle strength and function Decreased respiratory compliance Spontaneous pneumothorax |
Gastrointestinal system | Gut atrophy, bacterial translocation, and impaired immune function Delayed gastric emptying, gastric dilatation |
Musculoskeletal system | Reduced muscle mass and strength, myopathy Reduced bone mass, secondary fractures Impaired wound healing Impaired thermoregulation |
Renal system | Reduced glomerular filtration rate Total body water proportionally higher Proteinuria, uremia |
Electrolyte and metabolic | Hypokalemia Hypocalcemia Hypoglycemia Metabolic acidosis Increased cortisol |
Pharmacologic | Delayed or reduced absorption of drugs Decreased protein binding from hypoalbuminemia Prolonged treatment with nondepolarizing muscle relaxants Lower dosing thresholds for toxicity |
Treatment is aimed at balancing nutritional intake with energy needs, taking into consideration the level of activity or stress of the patient. When it is evident that patients will not be able to meet their nutritional needs, nutritional supplementation may be indicated, either through enteral (oral or tube) feeding or parenteral (intravenous) feeding. When possible, enteral support is preferred over parenteral support because of its relative simplicity, safety, lower cost, and decreased rates of complications. Total parenteral nutrition (TPN) is required when the gastrointestinal tract is not functional. When used for brief periods, peripheral parenteral nutrition may be provided; however, when long-term or high caloric support is indicated, central venous access is required to allow for the infusion of hypertonic solutions at a lower volume. Numerous complications are associated with TPN, including metabolic and electrolyte derangements, renal dysfunction, liver dysfunction, altered coagulation, bacterial translocation from the gastrointestinal tract, and infection or sepsis.
Malnutrition is associated with several complications in the perioperative period, including increased rates of infection, poor wound healing and anastomotic integrity, bacterial overgrowth in the gastrointestinal tract, increased time spent in the intensive care unit and hospital length of stay, and increased need for mechanical ventilation. It is also associated with increased mortality after organ transplant, major intraabdominal, or cardiothoracic surgeries. As such, it is important to identify patients who are malnourished and, when possible, intervene to improve their nutritional state in an effort to reduce complications and improve outcomes.
Assessing nutritional status preoperatively is complex; however, the combined use of a comprehensive history and physical examination and nutritional risk screening tool is a helpful approach. Certain laboratory testing may also help to identify malnourishment, including reduced serum protein markers, such as albumin, prealbumin, or transferrin. Of these, prealbumin may allow for the earliest detection of changes in nutritional status, given that its half-life is only 2 days; however, it should be measured in conjunction with C-reactive protein levels, as inflammation can raise the level of prealbumin and affect result interpretation. Reduced serum levels of cholesterol, zinc, iron, vitamin B 12 , or folic acid may also indicate malnourishment. In the postoperative setting the adequacy of nutritional support may be assessed by the patient's overall clinical course and wound healing. Daily clinical assessment, trend in lean body mass, calorimetry, and laboratory results may also inform the patient's nutritional status.
Refeeding syndrome describes the metabolic disturbance that occurs after rapid nutritional repletion in a severely malnourished patient. Hypophosphatemia is the hallmark disturbance of the syndrome and occurs for several reasons. Initial glucose load from feeding leads to increased insulin levels, which in turn result in a rapid movement of extracellular phosphate, potassium, and magnesium into the intracellular compartment. Insulin also leads to the production of molecules that require phosphate, such as adenosine triphosphate and 2,3-diphosphoglycerate, which leads to further phosphate depletion. Hypophosphatemia in turn leads to tissue hypoxia, myocardial dysfunction, respiratory failure, hemolysis, rhabdomyolysis, and seizures. Refeeding syndrome can be avoided by having a cautious and carefully titrated approach to nutritional repletion.
For severely malnourished patients, TPN or enteral feeding should be administered for 7 to 10 days before an electric surgery to improve outcomes. Nutritional replacement should be continued as long as possible before a surgical procedure. With TPN, consideration should be made regarding the presence of insulin in the infusion, as regular monitoring of the patient's glucose and electrolytes may be required. With enteral replacement, consideration should be made regarding the patient's risk of aspiration of gastric contents with the benefit of continued nutritional replacement to keep the patient at goal level.
Intraoperative goals for anesthetic management rely on considering the various metabolic, physiologic, and pharmacologic changes in malnourished patients. General principles for management include preventing hypoglycemia, preventing hypothermia, treating and preventing dehydration, correcting electrolytes, identifying and treating infections, correcting micronutrient deficiencies, careful positioning and padding, and emotional support.
Inflammatory bowel disease (IBD) is a group of inflammatory disorders of the small intestine and colon. The two principal types are ulcerative colitis (UC) and Crohn disease (CD). UC primarily affects the colon and rectum and results in relapsing and remitting episodes of mucosal inflammation. CD may involve any portion of the gastrointestinal tract from the mouth to the perianal area and results in transmural inflammation, which may be complicated by fibrosis, stricture, fistula, or abscess formation. Although the two disorders have some distinct pathologic and clinical characteristics, there is substantial overlap, and differentiation of the two may be difficult.
The pathophysiology of IBD is complex and arises from interaction of both genetic and environmental factors, ultimately triggering an immunologic response and inflammation in the intestine. Known environmental risk factors include smoking, sedentary lifestyle, sleep deprivation, stress, appendectomy, antibiotics, oral contraceptives, and nonsteroidal antiinflammatory drugs (NSAIDs). Diagnosis is often made based on the location and nature of the intestinal and extraintestinal manifestations coupled with findings on imaging and endoscopy. Fecal calprotectin may also suggest the diagnosis, but it is not specific for IBD.
Medical therapy for both types is aimed at alleviating the severity of symptoms and is not curative. In addition to medical therapy, up to 70% of patients may require surgical intervention. Although surgery cannot definitively cure CD, most cases of UC can be cured by proctocolectomy, although the patient's extraintestinal symptoms may persist. In patients with advanced IBD of either type surgery may be indicated for various reasons, including disease complications (fistula, stricture, abscess, toxic megacolon, perforation), surgical complications (adhesions, bowel obstruction), intractable symptoms, or cancer prevention.
As the proportion of older patients with IBD is increasing, there is an increase in the complexity of comorbid conditions that require care in the perioperative setting. Increased perioperative morbidity of patients with IBD is seen in those who are malnourished, aged 60 to 80 years, on long-term immunosuppressive therapy, requiring emergent operation, and treated in low-volume centers. Type of surgical intervention is also related to perioperative morbidity, with increased risk in patients undergoing a total proctocolectomy with J pouch rather than ileostomy, a repair for fistulizing disease rather than strictureplasty or stoma revision, and an open rather than laparoscopic approach.
Before elective surgery, medical optimization should be performed to address possible nutritional deficiencies and associated coagulopathy, hypovolemia, and electrolyte or acid–base disturbance in order to reduce the associated morbidity. Because of the elevated risk for venous thromboembolic events in patients with IBD, perioperative pharmacologic prophylaxis is recommended. Perioperative medical management in patients with IBD varies depending on the type of IBD, the clinical circumstance of the patient, and the urgency of the surgery. The classes of medications used for patients with IBD include antidiarrheals, antiinflammatories, immunosuppressants, antibiotics, and other investigational drugs. Special consideration should be taken requiring the discontinuation and resumption of each type of immunosuppressive medication, as failure to hold or continue them may increase the risk of perioperative complications. Glucocorticoids should continue throughout the perioperative period with consideration for supplemental stress dosing before surgery.
Although no specific type of anesthetic is preferred for patients with IBD, consideration should be taken regarding the interaction of common IBD drugs with anesthetic medications. Cyclosporine increases minimum alveolar concentration of volatile anesthetics. Azathioprine may partially antagonize the effect of nondepolarizing neuromuscular blocking agents, and cyclosporine and infliximab may enhance their potency.
Gastroesophageal reflux disease (GERD) is a condition defined by the symptoms and complications associated with the reflux of gastric contents through the lower esophageal sphincter (LES) into the esophagus. Some degree of reflux is physiologic, but for patients with GERD, reflux is pathologic and leads to symptoms or mucosal injury. The classic symptoms of GERD are heartburn (burning retrosternal sensation) and regurgitation (perception of flow of refluxed gastric contents into the hypopharynx or mouth). The prevalence of heartburn and/or regurgitation symptoms is between 10% and 30% worldwide. Other nonspecific manifestations of GERD include dysphagia, globus sensation, chest pain, laryngitis, hoarseness, cough, dental erosions, adult-onset asthma, and aspiration.
Several mechanisms contribute to the development of GERD, including the imbalance of symptom-eliciting factors and defensive factors. Symptom-eliciting factors include reflux events, acidity of refluxed contents, and esophageal hypersensitivity. Defensive factors include esophageal acid clearance and mucosal integrity. Symptom severity is reflective of this imbalance in combination with impaired esophageal mobility, LES function, and/or gastric motility. Normally, the LES acts as an antireflux barrier at the level of the gastroesophageal junction (GEJ). The LES contributes to reflux prevention by maintaining a pressure higher than intraabdominal (or intragastric) pressure. Reflux occurs if the LES barrier becomes incompetent, such as with transient LES relaxations (i.e., belching), a hypotensive LES (reduced LES muscle tone and LES pressure), or an anatomic disruption of the LES. In patients with normal LES anatomy and function reflux can still occur if intraabdominal pressure exceeds LES pressure.
Several conditions are associated with the development of GERD, including hiatal hernia, obesity, pregnancy, obstructive sleep apnea, gastric hypersecretion, gastric outlet obstruction, gastric neuropathy, and increased intraabdominal pressure ( Table 29.4 ).
Condition | Mechanism | Comments |
---|---|---|
Hiatal hernia | Esophageal dysmotility, impaired emptying, cephalad displacement of LES into thoracic cavity, supradiaphragmatic postprandial acid pocket | Multifactorial |
Obesity and weight gain | Increased intraabdominal pressure, LES dysfunction | Also increased incidence of hiatal hernia |
Pregnancy | Hormonal factors (estrogen and progesterone-mediated reduction in LES tone), mechanical factors (gravid uterus causing increased intraabdominal pressure, delayed gastric emptying and decreased bowel transit) | Also see Chapter 33 |
Food and medications | LES dysfunction | Large meals, fatty foods, spicy foods, alcohol; medications may include aspirin/NSAIDs, anticholinergics, antidepressants |
Diagnosis is made based on a combination of symptom presentation, objective testing (endoscopy, ambulatory reflux monitoring), and response to empiric antisecretory therapy. Conservative management with lifestyle modification and medications are the mainstay of treatment for GERD. Lifestyle interventions include weight loss, head of bed elevation, and smoking cessation. Further, avoidance of late-night meals or foods that can potentially aggravate symptoms by lowering LES tone is recommended.
Drug therapies are aimed at relieving symptoms through several mechanisms ( Table 29.5 ).
Medication | Mechanism | Comments |
---|---|---|
Antacids | Neutralize gastric fluid acidity by providing base to react with hydrogen ions | Antacids can be particulate (e.g., TUMS) or nonparticulate (e.g., Bicitra). |
Mucoprotective drugs (e.g., sucralfate) | Provide a mucosal barrier from stomach acids | |
Prokinetic agents (e.g., metoclopramide) | Promote esophageal and gastric motility through the combined effect of increased muscarinic activity and dopamine and serotonin receptor antagonism | Metoclopramide may cause extrapyramidal side effects, such as tardive dyskinesia. |
Histamine 2 -receptor antagonists (e.g., famotidine) | Reduce the secretion of gastric acid | Histamine 2 -receptor antagonists may cause adverse central nervous system effects, such as confusion, agitation, and psychosis, especially in the elderly. |
Proton pump inhibitors (PPIs; e.g., pantoprazole) | Reduce the secretion of gastric acid | PPIs provide faster and more complete symptom relief and wound healing. Certain PPIs have drug–drug interactions, including inhibiting the metabolism and elimination of warfarin, digoxin, phenytoin, and benzodiazepines. |
Patients with GERD are at greater risk for aspiration. As such, anesthetic planning and management aim to minimize the chance for pulmonary aspiration of gastric contents and its associated morbidity. Depending on the volume, acidity, and composition of the gastric contents, aspiration may lead to airway obstruction, chemical injury and inflammation, pneumonia, acute respiratory distress syndrome, and/or respiratory failure. Risk factors for aspiration pneumonitis include gastric fluid pH less than 2.5, volume of aspirate more than 0.4 mL/kg, aspirate containing particulate matter, and pregnancy greater than 18 weeks' gestation. Premedication with antacids or histamine2-receptor antagonists may help to reduce the extent of injury if aspiration occurs, and prokinetic agents may help to reduce the aspirate volume. Proton pump inhibitors (PPIs) should be continued leading up to surgery.
Rapid-sequence induction and intubation (RSII) is often the induction technique of choice in patients at risk of aspiration pneumonitis. The goal of RSII is to complete the sequence of events from awake with intact airway reflexes to endotracheal intubation with the cuff inflated within the shortest time interval allowable. It is during this interval that the complete loss of airway reflexes occur and pulmonary aspiration risk is the highest. If a difficult intubation is anticipated on preoperative airway evaluation, an awake intubation may be indicated over an RSII. With RSII, achieving adequate depth of anesthesia (with or without neuromuscular blockade) is essential to avoid coughing, straining, or active vomiting with airway manipulation. Positive-pressure ventilation is avoided between induction and intubation to decrease the risk of gastric insufflation. Thorough preoxygenation and apneic oxygenation are necessary to increase the time until hypoxemia develops with apnea. Positioning with the head of the bed elevated places the larynx above the LES and aids in reducing the risk of passive regurgitation and aspiration. Although the application of cricoid pressure during RSII is often used to reduce the incidence of aspiration of gastric contents, its use is controversial. Multiple studies of cricoid pressure during RSII provide inconclusive results regarding technique and efficacy, and some studies suggest potential harm with cricoid pressure. Patients at risk for aspiration on induction and intubation are also at risk on emergence and extubation. Precautions to minimize aspiration during emergence include decompressing the stomach with an orogastric tube, elevating the head of the bed, and ensuring intact airway reflexes before extubation.
Surgical management of GERD is reserved for patients unable to tolerate medical therapy, for those with persistent symptoms necessitating long-term therapy, or for those who develop complications despite optimal medical therapy. Of the various endoscopic and surgical interventions available, the most common antireflux operation is the Nissen fundoplication. The operation is most often performed laparoscopically and consists of reducing the herniated stomach, repairing the diaphragmatic defect, and performing a gastric wrap around the stomach and LES to prevent the regurgitation of gastric contents. Although the Nissen fundoplication is the most effective and durable antireflux procedure, it also has the greatest potential for postoperative dysphagia, difficulty with vomiting, and gas bloating.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here